Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma

Both SEER and institutional data support substantial underestimation of nodal involvement by clinical staging. This finding has implications in decisions regarding neoadjuvant therapy and analysis of outcomes in the absence of pathologic staging.